Director, Head of Translational Imaging, Clinical Pharmacology and Translational Medicine

Company: Eisai US
Location: Cambridge
Posted on: November 23, 2020

Job Description:

Director, Head of Translational Imaging, Clinical Pharmacology and Translational Medicine Cambridge At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai?s human health care (hhc) mission. We?re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer?s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you. Job Description Eisai is searching for a creative, resourceful, integrative thinker and expert in the PET/MR imaging field in neurology to support clinical and translational research in Neuroscience Business Group. Focus will be primarily on PET imaging to design and plan clinical imaging studies for various NBG clinical programs and interact with imaging vendors, help manage imaging studies, participate in data analysis, modeling and presentation of results to International Project Teams. Stay abreast of the neuroimaging field in neuroscience with tight communication with key opinion leaders in academia and industry, and provide recommendations for imaging strategies, provide guidance for selection of methods of study design and analysis for PET tracers and functional/structural MRI, and other of medical imaging modalities. Be key driver of the interaction with Imaging CRO?s regarding the design of clinical studies, plan meetings, provide agenda, and lead discussion. Provide a global resource for education, preclinical and translational strategy and application of PET/MRI methodology. Manage strategic partnerships with key opinion leaders and CRO's for successful execution of translational PET imaging studies. Additional responsibilities include but are not limited to: Quantitate and interpret imaging data Support other Clinical imaging research activities including PET tracer identification and study utilization External collaboration with Key Opinion Leaders in neuroimaging Drive PET tracer development and utilization strategy Interact with Imaging CRO?s Regulatory interactions regarding PET imaging in clinical development Job Qualifications: PhD equivalent plus at least 10 years of industry experience in relevant field; Expert ability to plan, optimize and conduct PET/MR imaging studies; Ability to quantitate and interpret imaging data; Experience communicating results to the project team members; Ability to support other imaging research activities; Experience preparing reports and giving presentations internally and externally; Experience working collaboratively with team members, global unit members; key opinion leaders and CROs. Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans. Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information: At Eisai Inc.,--human health care--(hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of--Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at--www.eisai.com/US and follow us on Twitter and LinkedIn . All data that is entered should be in the correct case, please refrain from using all caps.

Keywords: Eisai US, Cambridge , Director, Head of Translational Imaging, Clinical Pharmacology and Translational Medicine, Executive , Cambridge, Massachusetts